Du är här

2015-10-07

Biotie Therapies Oyj: Issue of new treasury shares of Biotie Therapies Corp without consideration

BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 7 October 2015 at 9 a.m.

Issue of new treasury shares of Biotie Therapies Corp without consideration

Biotie Therapies Corp. (Nasdaq Helsinki BTH1V; NASDAQ: BITI) ("Biotie" or the
"Company") announces that, pursuant to the authorization of the Annual
General Meeting of Shareholders held on 26 May 2015, the Board of Directors
of Biotie has resolved to issue 106,088,336 shares ("Treasury Shares") to the
Company itself without consideration in accordance with Chapter 9 Section 20
of the Finnish Companies Act (624/2006, as amended). The Treasury Shares are
issued to facilitate the timely delivery by the Company of such Treasury
Shares underlying the warrants issued in May 2015 to certain US investors and
certain existing shareholders based on the authorisation granted by the
Annual General Meeting of the Company on 26 May 2015, if and when such
above-mentioned warrants are exercised.

The Treasury Shares will be registered with the Finnish Trade Register on or
about 8 October 2015, and admitted to trading on NASDAQ OMX Helsinki Ltd on
or about 9 October 2015. The Treasury Shares are of the same class as the
existing shares in the Company.

After the registration of the Treasury Shares with the Finnish Trade Register,
Biotie will have 1,086,940,271 shares in total of which 978,246,244 will be
outstanding shares. The total number of shares held by the Company or its
fully owned subsidiary after the share issue is 108,694,027 shares (9.99 per
cent).

The warrants may be exercised, in whole or in part, and the Treasury Shares
may be conveyed to the exercising warrantholders, at any time during the
period of 1 November 2015 to 1 November 2020. The complete terms and
conditions of the warrants are available on the Company's website.

In Turku, 7 October 2015

Biotie Therapies Corp.

Timo Veromaa
President and CEO

For further information, please contact:

Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com

www.biotie.com

DISTRIBUTION:

NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biotie Therapies Oyj via Globenewswire

HUG#1957239

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.